Finance | 31 January, 2025 at 1:13 PM
Dealmaking volume stable but value is down
65% of all big pharma revenues now come from dealmaking, confirming a need for robust inorganic growth and value creation strategies.
65% of all big pharma revenues now come from dealmaking, confirming a need for robust inorganic growth and value creation strategies.
Currently, more than 2.5 million customers can access the flexible financing options available in My Wallet.
On February 1, 2025, Cemacon, the market leader of ceramic blocks in Romania, finalizes the merger process with Euro Caramida.
A divergence in monetary policy between the ECB and the US Federal Reserve could have significant ramifications for capital flows.
65% of all big pharma revenues now come from dealmaking, confirming a need for robust inorganic growth and value creation strategies.
The bulk of this debt, RON 772.92 billion, was government securities. Borrowing amounted to RON 143.42 billion.